We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Symcel

News List

Symcel partners with Karolinska Institutet to validate calScreener™ in clinical antimicrobial susceptibility testing biospace
April 13, 2018
Symcel has partnered with the Karolinska Institutet in a Horizon 2020 funded project.
Symcel secures €3.6 million Horizon 2020 Phase II grant biospectrumasia
November 30, 2017
Antimicrobial resistance is increasing rapidly often causing infections that are extremely difficult to treat and for which no single antibiotic has an effect
€3.6 million Horizon 2020 Phase II grant secured by Symcel in battle against antibiotic resistance pharmaasia
November 28, 2017
The aim is for multi-resistant bacterial sepsis infections to be validated utilising the sensitive Symcel screening technology.